{"id":"https://openalex.org/W7221663588","doi":"https://doi.org/10.64898/2026.10.06.757024","title":"RNA evidence supports clinical stage antibody drug targets in oncology","display_name":"RNA evidence supports clinical stage antibody drug targets in oncology","publication_year":2026,"publication_date":"2026-10-13","ids":{"openalex":"https://openalex.org/W7221663588","doi":"https://doi.org/10.64898/2026.10.06.757024"},"language":"en","primary_location":{"id":"doi:10.64898/2026.10.06.757024","doi":"https://doi.org/10.64898/2026.10.06.757024","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.06.757024","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/13/2026.10.06.757024.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/13/2026.10.06.757024.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064588609","display_name":"Daniele Pozzobon","orcid":"https://orcid.org/0000-0003-0817-9247","observed_orcids":["https://orcid.org/0000-0003-0817-9247"]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK","NL","US"],"is_corresponding":false,"raw_author_name":"Daniele Pozzobon","raw_affiliation_strings":["Genmab"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab","institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158585324","display_name":"Nichal Khusial","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK","NL","US"],"is_corresponding":false,"raw_author_name":"Nichal Khusial","raw_affiliation_strings":["Genmab"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab","institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079307726","display_name":"Roberto Spreafico","orcid":"https://orcid.org/0000-0001-8282-7658","observed_orcids":["https://orcid.org/0000-0001-8282-7658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roberto Spreafico","raw_affiliation_strings":["Absci"],"raw_orcid":"https://orcid.org/0000-0001-8282-7658","affiliations":[{"raw_affiliation_string":"Absci","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090373934","display_name":"Attila Csala","orcid":"https://orcid.org/0000-0003-4969-5555","observed_orcids":["https://orcid.org/0000-0003-4969-5555"]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK","NL","US"],"is_corresponding":true,"raw_author_name":"Attila Csala","raw_affiliation_strings":["Genmab"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab","institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210102253","https://openalex.org/I4210163256"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5090373934"],"corresponding_institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210102253","https://openalex.org/I4210163256"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6137999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6137999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.17749999463558197,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11289","display_name":"Single-cell and spatial transcriptomics","score":0.05299999937415123,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-cell-rna-sequencing","display_name":"single-cell RNA sequencing","score":0.8259999752044678},{"id":"https://openalex.org/keywords/bulk-rna-sequencing","display_name":"bulk RNA-seq","score":0.9419999718666077},{"id":"https://openalex.org/keywords/target-prioritization","display_name":"target prioritization","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tumor-specificity","display_name":"tumor specificity","score":0.8500000238418579},{"id":"https://openalex.org/keywords/surfaceome","display_name":"surfaceome","score":0.8600000143051147},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.6100000143051147},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.5669999718666077},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cell-type-specificity","display_name":"cell type specificity","score":0.6290000081062317},{"id":"https://openalex.org/keywords/tumor-associated-genes","display_name":"tumor-associated genes","score":0.3179999887943268},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.42800000309944153},{"id":"https://openalex.org/keywords/cancer-immunotherapy-targets","display_name":"cancer immunotherapy targets","score":0.4449999928474426},{"id":"https://openalex.org/keywords/cancer-immunotherapy-biomarkers","display_name":"cancer immunotherapy biomarkers","score":0.35199999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6836000084877014},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5443000197410583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5116000175476074},{"id":"https://openalex.org/C2777615720","wikidata":"https://www.wikidata.org/wiki/Q11888847","display_name":"Prioritization","level":2,"score":0.5},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.48019999265670776},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4350000023841858},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.39399999380111694},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.37229999899864197},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.34619998931884766},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.31769999861717224},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3061000108718872},{"id":"https://openalex.org/C112190416","wikidata":"https://www.wikidata.org/wiki/Q2124450","display_name":"RNA extraction","level":4,"score":0.3000999987125397},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2964000105857849},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2621000111103058}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.10.06.757024","doi":"https://doi.org/10.64898/2026.10.06.757024","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.06.757024","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/13/2026.10.06.757024.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.10.06.757024","doi":"https://doi.org/10.64898/2026.10.06.757024","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.06.757024","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/13/2026.10.06.757024.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221663588.pdf","grobid_xml":"https://content.openalex.org/works/W7221663588.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1985255881","https://openalex.org/W2013416277","https://openalex.org/W2078129874","https://openalex.org/W2127805347","https://openalex.org/W2130925862","https://openalex.org/W2146512944","https://openalex.org/W2158485828","https://openalex.org/W2531470489","https://openalex.org/W2556877281","https://openalex.org/W2582743722","https://openalex.org/W2607211817","https://openalex.org/W2789816271","https://openalex.org/W2898873576","https://openalex.org/W3133859624","https://openalex.org/W4211238337","https://openalex.org/W4214566503","https://openalex.org/W4390055385","https://openalex.org/W4393970982","https://openalex.org/W4394892101","https://openalex.org/W4400520109","https://openalex.org/W4401458350","https://openalex.org/W4404996294","https://openalex.org/W4406453484","https://openalex.org/W4406778273","https://openalex.org/W4406786794","https://openalex.org/W4407388488","https://openalex.org/W7213470189"],"related_works":["https://openalex.org/W4282934025","https://openalex.org/W4393970982","https://openalex.org/W4404137708","https://openalex.org/W7123837462","https://openalex.org/W6958315268","https://openalex.org/W3163807833","https://openalex.org/W4200096106","https://openalex.org/W4414534000","https://openalex.org/W2810808169","https://openalex.org/W2125733068"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2],"selection":[3,138],"of":[4,54,111,282,336],"efficacious":[5],"and":[6,15,18,33,64,88,179,219,248,357],"safe":[7],"antibody-based":[8,113],"oncology":[9,114,367],"targets":[10,78,115,181,250,356],"depends":[11],"on":[12],"tumor":[13,31,73,82,321],"specificity":[14,32,353],"normal-tissue":[16],"expression,":[17],"remains":[19],"challenging.":[20],"Bulk":[21],"RNA-seq":[22],"can":[23,362],"identify":[24],"tumor-enriched":[25],"surface":[26],"genes,":[27],"but":[28],"may":[29],"obscure":[30],"normal-cell":[34,217,326],"expression":[35,49],"patterns":[36],"that":[37,349,359],"are":[38,306,343],"relevant":[39,366],"to":[40,287],"the":[41,223,228,273],"therapeutic":[42],"window.":[43],"We":[44,60],"evaluated":[45,105],"whether":[46],"single-cell":[47,65,96,145,201,224,260,274,350],"RNA-seq-derived":[48],"features":[50,91,305],"improve":[51],"retrospective":[52],"prioritization":[53],"clinically":[55,310,365],"pursued":[56,311],"antibody":[57,313,338],"targets.":[58,214,314,368],"Methods":[59],"developed":[61],"a":[62,99,107,199],"bulk":[63,94,151,204,263],"RNA":[66],"expression-based":[67],"ranking":[68,304,361],"framework":[69],"across":[70,139,153,231,284],"six":[71],"solid":[72],"indications.":[74],"4,532":[75],"candidate":[76],"surfaceome":[77],"were":[79,133],"scored":[80],"using":[81,116],"Specificity":[83,131,146,152,188,192,288,299,322],",":[84,87],"normal":[85],"Safety":[86,218,268,327],"blood":[89,220],"Sink":[90,221],"derived":[92],"from":[93],"RNA-seq,":[95,97],"or":[98],"combined":[100,324],"modality.":[101],"Ranking":[102],"performance":[103],"was":[104],"against":[106],"curated":[108],"validation":[109],"set":[110],"tumor-associated":[112,312],"logistic":[117],"regression,":[118],"with":[119,135,294,325,346],"odds":[120],"ratios":[121],"(ORs)":[122],"reported":[123],"per":[124],"one-standard-deviation":[125],"increase":[126],"in":[127,205,264,272,344],"score.":[128],"Results":[129],"Higher":[130],"scores":[132],"associated":[134],"clinical-stage":[136,355],"target":[137,339],"all":[140],"modalities.":[141],"In":[142],"cross-indication":[143],"meta-analysis,":[144],"showed":[147,189,227,257],"higher":[148],"ORs":[149,278],"than":[150],"clinical":[154],"phase":[155],"thresholds,":[156],"including":[157],"Phase":[158,165,172,211,238,243],"\u2265":[159,166,173,212,234,239,244],"1":[160,235],"(OR":[161,168,175,182],"2.56":[162],"versus":[163,170,177,184],"1.81),":[164],"2":[167,240],"2.77":[169],"1.88),":[171],"3":[174,213,245],"3.53":[176],"2.04)":[178],"Approved":[180,249],"3.51":[183],"1.74).":[185],"Combined":[186],"bulk-and-single-cell":[187],"intermediate":[190],"enrichment.":[191,301],"score":[193,226,255],"alone":[194],"did":[195],"not":[196],"consistently":[197,258],"show":[198],"significant":[200,259],"advantage":[202,261],"over":[203,262],"paired":[206,265],"indication-level":[207,266],"comparisons,":[208],"except":[209],"for":[210],"After":[215],"adding":[216],"features,":[222],"general":[225,254],"strongest":[229],"enrichment":[230],"thresholds":[232,285],"(Phase":[233],"OR":[236,241,246,251],"3.61,":[237],"4.16,":[242],"5.57,":[247],"4.25).":[252],"This":[253],"also":[256],"comparisons.":[267],"contributed":[269],"most":[270,318],"strongly":[271],"modality,":[275],"increasing":[276],"meta-analytic":[277],"by":[279,292],"an":[280,333],"average":[281],"\u223c36%":[283],"compared":[286],"alone.":[289],"Performance":[290],"varied":[291],"indication,":[293],"breast":[295],"cancer":[296],"showing":[297],"weaker":[298],"-based":[300],"Conclusion":[302],"Expression-derived":[303],"retrospectively":[307],"enriched":[308],"among":[309],"Single-cell":[315],"evidence":[316,348],"is":[317,323],"informative":[319],"when":[320],"information,":[328],"supporting":[329],"its":[330],"use":[331],"as":[332],"interpretable":[334],"component":[335],"early":[337],"prioritization.":[340],"These":[341],"findings":[342],"alignment":[345],"recent":[347],"RNA-based":[351],"cell-type":[352],"supports":[354],"demonstrate":[358],"expression-driven":[360],"systematically":[363],"recover":[364]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-14T00:00:00"}